JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulé, S. J.
Right arrow Articles by Gorodetzky, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulé, S. J.
Right arrow Articles by Gorodetzky, C. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 3, 632-645, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


PHYSIOLOGIC DISPOSITION OF H3-CYCLAZOCINE IN NONTOLERANT, TOLERANT AND ABSTINENT DOGS

S. J. Mulé 1 and C. W. Gorodetzky 1

1 National Institute of Mental Health, Addiction Research Center, Lexington, Kentucky

This study was initiated in order to correlate the distribution and metabolism of H3-cyclazocine with its pharmacologic effects. A method specific for the estimation of H3-cyclazocine in biologic tissue and fluids was developed with a minimal sensitivity of 3 ng/ml of biologic material. Urine, fecal and plasma levels were determined in the same nontolerant, tolerant and abstinent dogs following a 1.25-mg/kg (free base) subcutaneous injection of H3-cyclazocine. The mean percentage recovery of the administered dose from urine and feces for both free and conjugated drug over a period of 120 hr was 43.7% from nontolerant dogs, 58.5% from tolerant dogs and 40.7% from abstinent dogs. Mean plasma levels of free cyclazocine reached a maximum of 156 ng/ml at 30 min in both nontolerant and tolerant dogs, and then fell rapidly to a level of 6 ng/ml at 8 hr in these dogs. Maximal levels of 304 and 361 ng/ml of conjugated cyclazocine were found at 90 min in the nontolerant and tolerant dogs, respectively. Mean values of 60 to 80 ng/ml of conjugated cyclazocine were obtained for these animals at 8 hr. Maximal mean levels of 1215 and 1259 ng/g were obtained at 1 hr in cerebral cortex gray matter of nontolerant and tolerant dogs, respectively. In white matter, the mean levels were 895 to 1108 ng/g. At 6 hr, the values had fallen to 36 to 56 ng/g in nontolerant dogs, and 100 to 117 ng/g in tolerant dogs. The levels of drug in subcortical areas were similar to those observed in the cerebrum. No drug was found in the central nervous system of a 24-hr abstinent dog. The levels of drug in certain peripheral tissues paralleled central nervous system values, but were quite high in lung, kidney, spleen, liver and adrenals. The bile contained extremely high levels of free and conjugated drug. The results indicated that potency of cyclazocine but not latency of abstinence was correlated with distribution, and that the drug was markedly metabolized.

Submitted on April 25, 1966
Accepted on July 6, 1966




This article has been cited by other articles:


Home page
ScienceHome page
D. Lange, S. Roerig, J. Fujimoto, and R. Wang
Absence of cross-tolerance to heroin in morphine-tolerant mice
Science, April 4, 1980; 208(4439): 72 - 74.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.